APA (7th ed.) Citation

Gniewkiewicz, M., Gozdowska, J., Deborska‐Materkowska, D., Czerwinska, K., Perkowska‐Ptasinska, A., Burban, A., . . . Durlik, M. (2023). Potential utility of urinary chemokine CCL2 to creatinine ratio in prognosis of 5‐year graft failure and mortality post 1‐year protocol biopsy in kidney transplant recipients. Immunity, Inflammation & Disease, 11(6), 1. https://doi.org/10.1002/iid3.901

Chicago Style (17th ed.) Citation

Gniewkiewicz, Michal, Jolanta Gozdowska, Dominika Deborska‐Materkowska, Katarzyna Czerwinska, Agnieszka Perkowska‐Ptasinska, Anna Burban, Aleksandra Cieslik, Maciej Kosieradzki, and Magdalena Durlik. "Potential Utility of Urinary Chemokine CCL2 to Creatinine Ratio in Prognosis of 5‐year Graft Failure and Mortality Post 1‐year Protocol Biopsy in Kidney Transplant Recipients." Immunity, Inflammation & Disease 11, no. 6 (2023): 1. https://doi.org/10.1002/iid3.901.

MLA (9th ed.) Citation

Gniewkiewicz, Michal, et al. "Potential Utility of Urinary Chemokine CCL2 to Creatinine Ratio in Prognosis of 5‐year Graft Failure and Mortality Post 1‐year Protocol Biopsy in Kidney Transplant Recipients." Immunity, Inflammation & Disease, vol. 11, no. 6, 2023, p. 1, https://doi.org/10.1002/iid3.901.